CYTO marks the public debut of the Cytek Borealis™ system, a new 7-laser flow cytometer that integrates full spectrum flow cytometry with future cellular imaging capabilities in a single system. The ...
New 7-Laser Cytek Borealis™ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Aurora™ Evo System Enhancements for Automation and Workflow Efficiency Cytek Borealis™ Full Spectrum Flow ...
New 7-Laser Cytek Borealis™ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Aurora™ Evo System Enhancements for Automation and Workflow Efficiency FREMONT, Calif., June 02, 2026 ...
FREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- At CYTO 2026, the industry’s premier flow cytometry conference, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase ...
(MENAFN- GlobeNewsWire - Nasdaq) New 7-Laser Cytek BorealisTM System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek AuroraTM Evo System Enhancements for Automation and Workflow Efficiency ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Management highlighted ongoing revenue momentum in the U.S., led by academic and biopharma market strength. Recurring revenue penetration increased as a percentage of total revenue, with both reagents ...
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Cytek Biosciences First Quarter 2026 Earnings Conference Call. [Operator Instructions] I will now ...
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Good afternoon all, and welcome. My name is Fazi Kash, and I'll be moderating today's session. It is my pleasure to introduce Dr. Jiang, CEO and Chair; and Bill McCombe, CFO; Paul Goodson, Head of IR, ...
“Our third quarter results are encouraging and demonstrate the strength of our established brand and technology and our market leadership position,” said Wenbin Jiang, CEO of Cytek Biosciences. “As we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results